RecruitingNot ApplicableNCT06554470

Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy

Local Versus Systemic Methotrexate in Management of Uterine Ectopic Pregnancy: A Randomized Trial

Sponsor

Tanta University

Enrollment

34 participants

Start Date

Aug 15, 2024

Study Type

INTERVENTIONAL

Conditions

Methotrexate Local Systemic Uterine Ectopic Pregnancy

Summary

This study aims to compare local and systemic methotrexate in the management of uterine ectopic pregnancy regarding the duration of beta human chorionic gonadotropin (hCG) clearance and need for further management options.

Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Local Methotrexate and a drug called Systemic Methotrexate for people with local, methotrexate, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 20 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.